Salivary IL‐33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis

Abstract

ObjectivesToll‐like receptor‐2 (TLR2) signalling pathway is involved in the regulation of interleukin (IL)‐33 and its receptor suppression of tumorigenicity‐2 (ST2). This study aimed to compare salivary IL‐33 and soluble ST2 (sST2) levels of periodontitis patients with those of periodontally healthy individuals in relation to their TLR2 rs111200466 23‐bp insertion/deletion polymorphism within the promoter region.Materials and MethodsUnstimulated saliva samples were collected, and periodontal parameters were recorded from 35 periodontally healthy individuals and 44 periodontitis patients. Non‐surgical treatments were applied to periodontitis patients, and sample collections and clinical measurements were repeated 3 months following therapy. Salivary IL‐33 and sST2 levels were measured with enzyme‐linked immunosorbent assay kits, and TLR2 rs111200466 polymorphism was detected by polymerase chain reaction.ResultsElevated salivary IL‐33 (p = 0.007) and sST2 (p = 0.020) levels were observed in periodontitis patients, in comparison to controls. sST2 levels declined 3‐months following treatment (p < 0.001). Increased salivary IL‐33 and sST2 levels were found to be associated with periodontitis, with no significant relation to the TLR2 polymorphism.ConclusionPeriodontitis, but not TLR2 rs111200466 polymorphism, is associated with elevated salivary sST2 and possibly IL‐33 levels, and periodontal treatment is effective in reducing salivary sST2 levels.

Assessment of gingival crevicular fluid levels of IL33 and sST2 in periodontitis patients with stage I-III disease

“…In this investigation, the levels of GCF IL33 in periodontal disease patients were considerably greater than those in healthy periodontal conditions. These outcomes align with other research (21,22). Contrary to our findings, the levels of salivary IL-33 were unchanged in periodontitis patients (10)(11)(12).…”